vidarabine has been researched along with Histiocytosis, Non-Langerhans-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caenazzo, L; Calore, E; Cesaro, S; De Silvestro, G; Destro, R; Gazzola, MV; Marson, P; Messina, C; Pillon, M; Varotto, S; Zanesco, L | 1 |
| Akagi, T; Hayashi, K; Jin, ZS; Joko, H; Koirala, TR; Kondo, E; Munemasa, M; Oda, W; Ohara, N; Oka, T; Onoda, S; Takahashi, K; Tanaka, T; Yamada, M; Yoshino, T | 1 |
| Arizpe-Bravo, D; Garcés-Eisele, J; Ponce-de-León, S; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ; Sánchez-Sosa, S | 1 |
| Greene, V; Kanold, J; Schneider, P; Vannier, JP | 1 |
4 other study(ies) available for vidarabine and Histiocytosis, Non-Langerhans-Cell
| Article | Year |
|---|---|
Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Graft Survival; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2003 |
Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease.
Topics: Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cell Line; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Genome, Viral; Herpes Simplex; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulin G; Lymphoma; Lymphoproliferative Disorders; Papio; Phenotype; Prednisone; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Simplexvirus; Survival Analysis; Vidarabine; Vincristine | 2003 |
Tuberculosis-associated fatal hemophagocytic syndrome in a patient with lymphoma treated with fludarabine.
Topics: Adult; Antineoplastic Agents; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Tuberculosis; Vidarabine | 1998 |
Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Male; Remission Induction; Vidarabine | 2001 |